These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3318250)

  • 21. [Immunogenicity and protective properties for mice of the formalin-inactivated tick-borne encephalitis virus].
    Gut W; Jarzabek Z; Sadowski W; Kańtoch M
    Med Dosw Mikrobiol; 1986; 38(4):234-40. PubMed ID: 3561097
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activity of cytokines in immunization with a vaccine against experimental tick-borne encephalitis].
    Ignat'ev GM; Otrashevskaia EV; Vorob'eva MS
    Vopr Virusol; 2003; 48(2):22-5. PubMed ID: 12924094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoenzyme method in the diagnosis of tick-borne encephalitis].
    Bashkirtsev VN; Ivanov AP; Dekonenko EP; Pivanova GP; Vorob'eva MS
    Vopr Virusol; 1986; 31(1):96-100. PubMed ID: 3515766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concentrated and purified vaccine against tick-borne encephalitis prepared by ultracentrifugation and chromatography].
    El'bert LB; Krasil'nikov IV; Drozdov SG; Grachev VP; Pervikov IuV
    Vopr Virusol; 1985; 30(1):90-3. PubMed ID: 3993007
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectors of in vivo delayed hypersensitivity in experimental flavivirus infections and vaccination against tick-borne encephalitis in mice].
    Lipovka VA; Khozinskiĭ VV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):83-8. PubMed ID: 6098109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain.
    Gresíková M; Sekeyová M; Marcinka K; Ciampor F
    Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Concentrated purified vaccine against tick-borne encephalitis prepared by means of zonal ultracentrifugation. Development of the preparation].
    El'bert LB; Gagarina AV; Khanina MK; Krutianskaia GL; Grachev VP
    Vopr Virusol; 1980; (3):341-5. PubMed ID: 7434727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus.
    Heinz FX; Tuma W; Guirakhoo F; Kunz C
    J Biol Stand; 1986 Apr; 14(2):133-41. PubMed ID: 2428820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new prospective vaccine against tick-borne encephalitis].
    Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis].
    Vargin VV; Semenov BF
    Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Persistence of the tick-borne encephalitis virus in the vaccinated organism].
    Levina LS; Pogodina VV
    Vopr Virusol; 1988; 33(4):485-90. PubMed ID: 3195146
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation and Characterization of a Chimeric Tick-Borne Encephalitis Virus Attenuated Strain ChinTBEV.
    Wang HJ; Li XF; Qin CF
    Methods Mol Biol; 2016; 1403():285-93. PubMed ID: 27076137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Laboratory methods of controlling immunogenicity of vaccines against tick-borne encephalitis].
    Sokolova ED
    Tr Inst Im Pastera; 1989; 65():90-8. PubMed ID: 2560849
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation.
    Heinz FX; Kunz C; Fauma H
    J Med Virol; 1980; 6(3):213-21. PubMed ID: 7014784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid vaccination protocols for commercial vaccines against tick-borne encephalitis.
    Stephenson JR; Lee JM; Easterbrook LM; Timofeev AV; Elbert LB
    Vaccine; 1995; 13(8):743-6. PubMed ID: 7483789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.
    Kunz C; Heinz FX; Hofmann H
    J Med Virol; 1980; 6(2):103-9. PubMed ID: 7241091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vaccines, immunoglobulins, and test systems for the prevention and diagnosis of tick-borne encephalitis].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP
    Vopr Virusol; 2007; 52(6):30-6. PubMed ID: 18050715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.